Nonetheless, our findings are in-line with some of those reported in a cross-cancer case-control study (with blood collected at or after diagnosis) within the Uppsala-Umeå Comprehensive Cancer Consortium biobank; we replicated the reported association of GFAP with glioma and the associations of CNTN5, SLAMF7, MZB1, QPCT and TNFRSF13B with multiple myeloma31. This evidence concerns the gene TNFRSF13B and central nervous system cancer.